Tennessee Clinical Trials

Recruiting studies in Tennessee

• A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
  NCT07194265Severe Aortic StenosisGermantown, TN
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
  NCT07489066CarcinomaKnoxville, TN
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723Chronic Kidney Disease and HypertensionChattanooga, TN
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425Atopic DermatitisNashville, TN
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060Episodic MigraineMemphis, TN
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
  NCT04657068Advanced CancerChattanooga, TN
• Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
  NCT07192432HER2 Expressing Solid TumorsNashville, TN
• Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
  NCT07652242Triple Negative Breast Cancer (TNBC)Nashville, TN
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
  NCT05519085Relapsed or Refractory Multiple MyelomaGermantown, TN
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  NCT06623422Carcinoma, Non-Small-Cell LungChattanooga, TN
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularKnoxville, TN
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076Carcinoma, Non-Small-Cell LungChattanooga, TN

See all 1,802 recruiting Tennessee trials →

Clinical trials by Tennessee metro

• Nashville
• Memphis

Popular conditions in Tennessee

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Tennessee?

Corterve aggregates actively recruiting clinical trials with sites in Tennessee from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in Tennessee free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in Tennessee?

Tennessee research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.